60 Day FRN published

12900

Federal Register / Vol. 81, No. 48 / Friday, March 11, 2016 / Notices

The meeting will be held in the Board
Room located on the sixth floor of the
FDIC Building located at 550 17th Street
NW., Washington, DC
This Board meeting will be Webcast
live via the Internet and subsequently
made available on-demand
approximately one week after the event.
Visit https://
fdic.primetime.mediaplatform.com/#!/
channel/1232003497484/
Board+Meetings to view the event. If
you need any technical assistance,
please visit our Video Help page at:
http://www.fdic.gov/video.html.
The FDIC will provide attendees with
auxiliary aids (e.g., sign language
interpretation) required for this meeting.
Those attendees needing such assistance
should call 703–562–2404 (Voice) or
703–649–4354 (Video Phone) to make
necessary arrangements.
Requests for further information
concerning the meeting may be directed
to Mr. Robert E. Feldman, Executive
Secretary of the Corporation, at 202–
898–7043.
Dated: March 8, 2016.
Federal Deposit Insurance Corporation.
Valerie Best,
Assistant Executive Secretary.
[FR Doc. 2016–05609 Filed 3–9–16; 11:15 am]
BILLING CODE P

FEDERAL RESERVE SYSTEM

asabaliauskas on DSK3SPTVN1PROD with NOTICES

Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than March
28, 2016.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. James J. Dolan, as trustee of Voting
Trust Agreement, Patricia D. Dolan as
trustee of Royston Road Trust, all of

VerDate Sep<11>2014

17:56 Mar 10, 2016

Jkt 238001

Naples, Florida; Gregory F. Dolan as
trustee of JJD 2012 Family Trust,
Washington, DC; Emad Murrar, Homer
Glen, Illinois, and Alan Reasoner,
Round Lake, Illinois; to acquire voting
shares of Northwest Bancorporation of
Illinois, Inc., and thereby indirectly
acquire voting shares of First Bank and
Trust Company of Illinois, both in
Palatine, Illinois.
B. Federal Reserve Bank of Kansas
City (Dennis Denney, Assistant Vice
President) 1 Memorial Drive, Kansas
City, Missouri 64198–0001:
1. Margaret M. Brownlee, as trustee of
the Margaret March Brownlee Trust,
both of Orlando, Florida, and Paula
March Romanovsky, as trustee of the
Paula March Romanovsky Trust, both of
San Francisco, California, all as
members of the March family group; to
retain voting shares of Bank
Management, Inc., and thereby
indirectly retain voting shares of
FirstBank of Nebraska, both in Wahoo,
Nebraska.
C. Federal Reserve Bank of Dallas
(Robert L. Triplett III, Senior Vice
President) 2200 North Pearl Street,
Dallas, Texas 75201–2272:
1. Ann Biggs, as trustee of the Gordon
Brian Biggs Trust of 2012, the Edward
Barrett Biggs Trust of 2012, the Biggs
Grandchildren’s Trust, and the Glenn
Barrett Biggs Trust of 2012, all of San
Antonio, Texas; Steven Mack, Boerne,
Texas; and Jack Griggs, Abilene, Texas,
collectively a group acting in concert; to
acquire voting shares of Southwestern
Bancorp, Inc., and thereby indirectly
acquire voting shares of Texas Heritage
Bank, both in Boerne, Texas.
Board of Governors of the Federal Reserve
System, March 8, 2016.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2016–05495 Filed 3–10–16; 8:45 am]
BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–16–16TM; Docket No. CDC–2016–
0026]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of

SUMMARY:

PO 00000

Frm 00043

Fmt 4703

Sfmt 4703

its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project entitled ‘‘Prevalence
Survey of Healthcare-Associated
Infections (HAIs) and Antimicrobial Use
in U.S. Nursing Homes.’’ This
information collection request will
generate data to describe the
epidemiology and estimate the burden
of HAIs and antimicrobial use in US
nursing homes using the prevalence
survey method. Results will be used to
inform state prevention efforts and
federal priority setting for public health
initiatives to improve HAI prevention
and antimicrobial use.
DATES: Written comments must be
received on or before May 10, 2016.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2016–
0026 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
FOR FURTHER INFORMATION CONTACT:

E:\FR\FM\11MRN1.SGM

11MRN1

12901

Federal Register / Vol. 81, No. 48 / Friday, March 11, 2016 / Notices
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing

of HAIs; assessing the nature and extent
of antimicrobial use in U.S. healthcare
facilities; and assessing the nature and
extent of antimicrobial use.
Prevalence surveys, in which data are
collected in healthcare facilities during
a short, specified time period represent
an efficient and cost-effective alternative
to prospective studies of HAI and
antimicrobial use incidence. Given the
absence of existing HAI and
antimicrobial use data collection
mechanisms for nursing homes,
prevalence surveys represent a robust
method for obtaining the surveillance
data required to identify HAIs and
antibiotic use practices that should be
targeted for more intensive surveillance
and to guide and evaluate prevention
efforts.
The methods for the data collection
are based on those used in CDC hospital
prevalence surveys and informed by a
CDC pilot survey conducted in nine
U.S. nursing homes. The survey will be
performed by the CDC through the
Emerging Infections Program (EIP), a
collaboration with CDC and 10 state
health departments with experience in
HAI surveillance and data collection.
Respondents are nursing homes
certified by the Centers for Medicare &
Medicare Services in EIP states. Nursing
home participation is voluntary.
Nursing homes will be randomly
selected for participation, with a goal in
each EIP site of recruiting a total of 20
nursing homes.
There will be no anticipated costs to
respondents other than their time.
Information collection will last
approximately one year.

and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
Prevalence Survey of HealthcareAssociated Infections and Antimicrobial
Use in U.S. Nursing Homes—New—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated
infections (HAI) and encouraging
appropriate use of antimicrobials are
priorities of both the U.S. Department of
Health and Human Services and the
Centers for Disease Control and
Prevention (CDC). The burden and
epidemiology of HAIs and antimicrobial
use in U.S. nursing homes is currently
unknown. Understanding the scope and
magnitude of all types of HAIs in
patient populations across the spectrum
of U.S. healthcare facilities is essential
to the development of effective
prevention and control strategies and
policies.
HAI prevalence and antimicrobial use
estimates can be obtained through
prevalence surveys in which data are
collected in healthcare facilities during
a short, specified time period. Essential
steps in reducing the occurrence of
HAIs and the prevalence of resistant
pathogens include estimating the
burden, types, and causative organisms

asabaliauskas on DSK3SPTVN1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Average
burden per
response
(in hrs.)

Number of
responses per
respondent

Total burden
(in hrs.)

Type of respondents

Form name

Director of Nursing, Registered
Nurse, Infection Control and Prevention Officer.
Registered Nurse ..............................
Licensed Practical or Licensed Vocational Nurses.

Healthcare Facility Assessment .......

200

1

45/60

150

Residents by Location Form ............
...........................................................

200
200

38
38

20/60
20/60

2,533
2,533

Total ...........................................

...........................................................

........................

........................

........................

5,216

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–05520 Filed 3–10–16; 8:45 am]
BILLING CODE 4163–18–P

VerDate Sep<11>2014

17:56 Mar 10, 2016

Jkt 238001

PO 00000

Frm 00044

Fmt 4703

Sfmt 4703

E:\FR\FM\11MRN1.SGM

11MRN1